Posts

New study reveals disparities in the predictive perform...

#### Credit: The image was AI-created using DALL·E by OpenAI. Tibor V. Varga own...

Bennett A. Landman appointed as the next Editor-in-Chie...

BELLINGHAM, Washington, USA — On 1 January 2024, Bennett A. Landman, Vanderbilt ...

Impact Journals at SSP 45th Annual Meeting

BUFFALO, NY-May 17, 2023 – Impact Journals will be participating as an exhibitor...

SLU Institute for Healing Justice and Equity launches ‘...

ST. LOUIS — The Institute for Healing Justice and Equity (IHJE) at Saint Louis U...

NIR spectroscopy provides easy, cost-effective method f...

URBANA, Ill. – Food allergies pose a significant health risk, resulting in numer...

Hill Air Force Base and USU sign historic agreement

A new agreement between Utah State University and Hill Air Force Base will creat...

‘Charge density wave’ linked to atomic distortions in w...

UPTON, NY—What makes some materials carry current with no resistance? Scientists...

Uncovering universal physics in the dynamics of a quant...

New experiments using one-dimensional gases of ultra-cold atoms reveal a univers...

African Killifish could hold secrets to reversing muscl...

As we age, our muscles start to waste. Called sarcopenia, it happens to us all, ...

FDA approves drug for night sweats and hot flashes trea...

The FDA announced on Friday that a new non-hormonal medication, Veozah, also kno...

IntraOp Announces Phase II Trial for Carcinoma Therapy

IntraOp Medical Corporation has announced the second phase of the first-ever Ele...

Nido’s precision approach to brain drugs secures $109M ...

Amid the difficulties of the biotech market at present, investors are inclined t...

Phase I completion of Sanofi’s vWD therapy demonstrates...

Sanofi’s announcement provides a more positive outlook for the vWD market as it ...

Juno Pharmaceuticals buys Omega Laboratories

The merged entity represents one of the biggest specialist generic injectable op...

Nuvectis Pharma receives IND approval from FDA for NXP900

NXP900 is a new inhibitor of the SRC family of kinases with low nanomolar effect...

Gilead and Arcus Biosciences expand research collaborat...

Arcus will commence research programmes against up to four targets for inflammat...